[Findings on the causes and mechanisms in the development of undesirable effects of non-steroidal anti-rheumatic agents and their incidence in controlled clinical trials].
作者信息
Pavelka K, Vojtísek D, Kañkova D, Perlík F, Pelísková Z
出版信息
Fysiatr Revmatol Vestn. 1982 Jan;60(1):1-10.
PMID:7040188
Abstract
摘要
相似文献
1
2
[Incidence of undesirable side-effects in the course of controlled clinical experiments with non-steroid antirheumatic agents].
Vnitr Lek. 1978 Mar;24(3):260-9.
3
[Controlled clinical testing of a new anti-inflammatory agent].
Clin Ter. 1969 Apr 15;49(1):63-7.
4
[Antirheumatic therapy with new non-steroidal compounds (author's transl)].
MMW Munch Med Wochenschr. 1981 Sep 11;123(37):1377-82.
5
[Less effective analgetics and antirheumatics. Use and adverse effects].
Ugeskr Laeger. 1977 Jan;139(3):157-9.
6
[Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases].[阿扎丙宗在风湿性疾病中的药理特性及治疗效果]
Z Allgemeinmed. 1973 Apr 30;49(12):592-4.
7
[Non-steroidal anti-inflammatory drugs in the treatment of rheumatic diseases].[非甾体类抗炎药在风湿病治疗中的应用]
Nord Med. 1985;100(1):11-3.
8
Clinical trials in the rheumatic diseases.风湿性疾病的临床试验。
Clin Rheum Dis. 1983 Dec;9(3):489-698.
9
[The limits of our therapeutical possibilities in rheumatic diseases (author's transl)].[我们在风湿性疾病中治疗可能性的局限（作者译）]
Cas Lek Cesk. 1978 Jul 28;117(29-30):889-92.
10
[Criteria of the effectiveness of antirheumatic agents in controlled clinical trials].[抗风湿药物在对照临床试验中的有效性标准]
Ter Arkh. 1982;54(6):106-9.
Zotero 插件